Presepsin as a novel sepsis biomarker

doi:10.5847/wjem.j.issn.1920-8642.2014.01.002

Abstract

Abstract:

BACKGROUND: In 2004, a new biomarker sCD14-subtypes (presepsin) was found and its value was shown in the diagnosis and evaluation of sepsis. This article is a brief overview of the new biomarker.
DATA SOURCES: A literature search using multiple databases was performed for articles, especially meta-analyses, systematic reviews, and randomized controlled trials.
RESULTS: Compared with other markers, presepsin seems to have a better sensitivity and specificity in the diagnosis of sepsis. Presepsin as a biom1arker is not only suitable for the early diagnosis of sepsis, but also for the assessment of its severity and prognosis.
CONCLUSIONS: Presepsin has a higher sensitivity and specificity in the diagnosis of sepsis as a new biomarker, and is a predictor for the prognosis of sepsis. More importantly, preseptin seems to play a crucial role as a supplemental method in the early diagnosis of sepsis. Since there is no multicenter study on the relationship between presepsin and sepsis, further studies on the clinical values of presepsin are needed.

Key words: Presepsin, Sepsis, Diagnosis

Qi Zou, Wei Wen, Xin-chao Zhang. Presepsin as a novel sepsis biomarker[J]. World Journal of Emergency Medicine, 2014, 5(1): 16-19.

References 33

1	Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256. doi: 10.1097/01.CCM.0000050454.01978.3B pmid: 12682500
2	Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60. Epub 2007 Dec 4. doi: 10.1007/s00134-007-0934-2 pmid: 18058085
3	Soong J, Soni N. Sepsis: recognition and treatment. Clin Med 2012; 12:276-280.
4	Longo Dan. Harrison's principles of internal medicine. New York: McGraw-Hill, 2011: 271
5	Lu YH, Liu L, Qiu XH, Yu Q, Yang Y, Qiu HB. Effect of early goal directed therapy on tissue perfusion in patients with septic shock. World J Emerg Med 2013; 4:117-122. pmid: 25215104
6	Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohé J, et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 2009; 35:1859-1867. doi: 10.1007/s00134-009-1610-5 pmid: 19662382
7	Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med 2008; 34:2084-2091. pmid: 18523752
8	Wu HP, Chen CK, Chung K, Jiang BY, Yu TJ, Chuang DY. Plasma transforming growth factor-b1 level in patients with severe community-acquired pneumonia and association with disease severity. J Formos Med Assoc 2009; 108:20-27. doi: 10.1016/S0929-6646(09)60028-0 pmid: 19181604
9	Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005; 11:234-238. pmid: 16258819
10	Gong XW, Jiang Y. Structure, function and modulation of actin-related protein 2/3 complex. Sheng Li Ke Xue Jin Zhan 2004; 35:306-310. pmid: 15727206
11	Jiang Y, Liu AH, Huang QB. p38 MAPK signal is necessary for TNF-α gene expression in RAW cells. Acta Biochim Biophys Sin 1999; 31:9-15. pmid: 12142907
12	Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, et al. Characterrization of cytokine/chemkine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 2005; 171:850-857. doi: 10.1164/rccm.200407-857OC pmid: 15657466
13	Grunwald U, Krüger C, Westermann J, Lukowsky A, Ehlers M, Schütt C. An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. J Immunol Methods 1992; 155:225-232. doi: 10.1016/0022-1759(92)90289-6
14	Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 1995; 171:639-644. doi: 10.1093/infdis/171.3.639 pmid: 7533199
15	Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011; 49:937-939. doi: 10.1515/CCLM.2011.145 pmid: 21345045
16	Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 2011; 24:12-14.
17	Yin K, Dang SC, Zhang JX. Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis. World J Emerg Med 2011; 2:216-221. doi: 10.5847/wjem.j.1920-8642.2011.03.011 pmid: 25215013
18	Glück T, Silver J, Epstein M, Cao P, Farber B, Goyert SM. Parameters influencing membrane CDl4 expression and soluble CDl4 levels in sepsis. Eur J Med Res 2001; 6:351-358. pmid: 11549517
19	Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R. TLR2, TLR4, CDl4, CDllB, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, sever sepsis, and septic shock. Shock 2006; 25:351-357. doi: 10.1097/01.shk.0000217815.57727.29 pmid: 16670636
20	Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011; 17:764-769. doi: 10.1007/s10156-011-0254-x pmid: 21560033
21	Spanuth E, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble cd14 subtype) in emergency patients with early sepsis using the new assay PATHFAST Presepsin [C]//21st International Congress of Clinical Chemistry and Laboratory Medicine, IFCC-World Lab-Euro Med Lab, Berlin, 2011: 15-19.
22	Wang HX, Chen B. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis. World J Emerg Med 2011; 2:190-194. doi: 10.5847/wjem.j.1920-8642.2011.03.006 pmid: 25215008
23	Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7:210-217. doi: 10.1016/S1473-3099(07)70052-X pmid: 17317602
24	Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003. doi: 10.1097/01.CCM.0000226413.54364.36 pmid: 16715031
25	Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011; 66: doi: 10.1093/jac/dkr372 pmid: 21948964
26	Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecules, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77:F221-227. doi: 10.1136/fn.77.3.f221 pmid: 9462194
27	Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of perception in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012; 18:891-897. doi: 10.1007/s10156-012-0435-2 pmid: 22692596
28	JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31:2115-2127. doi: 10.1291/hypres.31.2115 pmid: 19139601
29	Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327. doi: 10.1097/01.CCM.0000298158.12101.41 pmid: 18158437
30	Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011; 412:2157-2161. doi: 10.1016/j.cca.2011.07.024 pmid: 21839732
31	Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med 2013; 51:2053-2062. pmid: 23740685
32	Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care 2013; 17:R244. [Epub ahead of print] doi: 10.1186/cc13070 pmid: 24138799
33	Umemura T, Ishikura H, Nakamura Y, Hoshino K, Nishida T, Kamitani T. Defining the need for a massive transfusion in severe blunt traumatic patients. Crit Care 2013; 17:S367.

[1]	Hui Chen, Yuanhua Lu, Songjie Bai, Yang Li, Tao Wang, Long Cai, Xinyi Yang, Yang Fang, Jianguo Wan, Yaqun Tang, Wenqiang Tao, Meiling Huang, Wei Zhong, Fen Liu, Kejian Qian. Stress-hyperglycemia ratio and glycemic variability predict severity and mortality in sepsis-associated acute respiratory distress syndrome [J]. World Journal of Emergency Medicine, 2026, 17(3): 250-257.
[2]	Yi Yao, Wenjin Li, Dejiang Hong, Ze Chen, Kai Peng, Guangju Zhao. Prediction model for quality of life in sepsis survivors one year after discharge [J]. World Journal of Emergency Medicine, 2026, 17(2): 105-112.
[3]	Zengzheng Ge, Xin Lu, Shiyuan Yu, Mubing Qin, Chao Gong, Qun Xu, Yanxia Gao, Joseph Harold Walline, Huadong Zhu, Yi Li. Diagnostic value of mismatch-negativity and P3a event-related potentials for sepsis-associated encephalopathy in non-sedated patients: a pilot study [J]. World Journal of Emergency Medicine, 2026, 17(2): 172-178.
[4]	Jinlan Ma, Li Peng, Hongming Yu, Jianfeng Xie, Ying Tang, Shenglin Su, Libing Ma, Xiaojun Yang. Single-cell transcriptomics reveals pathogen-specific monocyte heterogeneity and potential biomarkers in gram-positive versus gram-negative bloodstream infections [J]. World Journal of Emergency Medicine, 2026, 17(2): 162-171.
[5]	Xin Lu, Mubing Qin, Zengrui Song, Ying Chen, Huadong Zhu, Yanxia Gao, Yi Li. Normal initial lactate level in sepsis patients: is lactate still useful for prognosis prediction? [J]. World Journal of Emergency Medicine, 2026, 17(1): 57-64.
[6]	Yuhui Pan, Yanyan Ma, Ke Wan, Yizhou Xu, Guoxing Wang, Miaorong Xie. Endothelial cell injury: a crucial link in microcirculatory dysfunction associated with sepsis [J]. World Journal of Emergency Medicine, 2026, 17(1): 28-35.
[7]	Wei Gu, Jie Zhong, Chuanzhu Lyu, Guoqiang Zhang, Miaorong Xie, Yuefeng Ma, Wei Guo. An approach for the emergency diagnosis and treatment of sepsis-associated encephalopathy in elderly individuals: a literature review [J]. World Journal of Emergency Medicine, 2025, 16(5): 415-422.
[8]	Zesheng Wu, Fanghui Chen, Chen Xiao, Xue Zhao, Yuansheng Xu, Jinyan Fang, Yinyan Shao. Long-term cardiovascular outcomes and risk factors in adult sepsis survivors: a systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2025, 16(5): 423-430.
[9]	Qiaosheng Wang, Qiong Luo, Zhiwei Su, Yan Xu, Liangshan Peng, Yin Wen, Hongke Zeng, Hongguang Ding. Activation of the α7 nicotinic acetylcholine receptor mitigates cognitive deficits in mice with sepsis-associated encephalopathy by inhibiting microglial pyroptosis [J]. World Journal of Emergency Medicine, 2025, 16(5): 438-446.
[10]	Sen Jiang, Xiandong Liu, Tong Liu, Yi Gu, Bo An, Chunxue Wang, Dongyang Zhao, Haitao Zhang, Lunxian Tang. Performance of a novel medical artificial intelligence large language model on supporting decision-making for emergency patients with suspected sepsis [J]. World Journal of Emergency Medicine, 2025, 16(5): 447-455.
[11]	Quan Li, Yun Qu, Jinfang Xue, Hai Kang, Chuanzhu Lyu. Exploring lipid-modifying therapies for sepsis through the modulation of circulating inflammatory cytokines: a Mendelian randomization study [J]. World Journal of Emergency Medicine, 2025, 16(3): 256-261.
[12]	Peili Chen, Yan Ge, Huiqiu Sheng, Wenwu Sun, Jiahui Wang, Li Ma, Enqiang Mao. The role of early changes in routine coagulation tests in predicting the occurrence and prognosis of sepsis [J]. World Journal of Emergency Medicine, 2025, 16(2): 136-143.
[13]	Chunxue Wang, Dianyin Yang, Yuxin Zhu, Qian Yang, Tong Liu, Xiandong Liu, Dongyang Zhao, Xiaowei Bao, Tiancao Dong, Li Shao, Lunxian Tang. Circulating circular RNAs act as potential novel biomarkers for sepsis secondary to pneumonia: a prospective cohort study [J]. World Journal of Emergency Medicine, 2025, 16(2): 144-152.
[14]	Azzah S Alharbi, Raghad Hassan Sanyi, Esam I Azhar. Bacteria and host: what does this mean for sepsis bottleneck? [J]. World Journal of Emergency Medicine, 2025, 16(1): 10-17.
[15]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.

Presepsin as a novel sepsis biomarker Open Access

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Comments